Literature DB >> 34897378

A 10-year-old girl with low-grade B cell lymphoma complicated by anti-nuclear matrix protein 2 autoantibody-positive juvenile dermatomyositis.

Toshiyuki Kobayashi1, Taiji Nakano1, Hitoshi Ogata1, Noriko Sato1, Fumiya Yamaide1, Yoshiharu Yamashita1, Koji Chikaraishi1, Moeko Hino1, Ichizo Nishino2, Yuki Ichimura3, Naoko Okiyama3, Hiromichi Hamada1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34897378      PMCID： PMC9308377          DOI： 10.1093/rheumatology/keab922

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.046


× No keyword cloud information.
  8 in total

1.  Inflammatory Muscle Diseases.

Authors:  Marinos C Dalakas
Journal:  N Engl J Med       Date:  2015-07-23       Impact factor: 91.245

Review 2.  Juvenile dermatomyositis/polymyositis and lymphoma.

Authors:  Joerg-Patrick Stübgen
Journal:  J Neurol Sci       Date:  2017-03-27       Impact factor: 3.181

3.  Association of Dermatomyositis Sine Dermatitis With Anti-Nuclear Matrix Protein 2 Autoantibodies.

Authors:  Michio Inoue; Jantima Tanboon; Shinya Hirakawa; Hirofumi Komaki; Takeshi Fukushima; Hiroyuki Awano; Takashi Tajima; Kenji Yamazaki; Ryutaro Hayashi; Tatsuo Mori; Kazumoto Shibuya; Takahiko Yamanoi; Hajime Yoshimura; Tomohiro Ogawa; Atsushi Katayama; Fuminobu Sugai; Yoichi Nakayama; Satoko Yamaguchi; Shinichiro Hayashi; Satoru Noguchi; Hisateru Tachimori; Naoko Okiyama; Manabu Fujimoto; Ichizo Nishino
Journal:  JAMA Neurol       Date:  2020-07-01       Impact factor: 18.302

4.  Sarcoplasmic MxA expression: A valuable marker of dermatomyositis.

Authors:  Akinori Uruha; Atsuko Nishikawa; Rie S Tsuburaya; Kohei Hamanaka; Masataka Kuwana; Yurika Watanabe; Shigeaki Suzuki; Norihiro Suzuki; Ichizo Nishino
Journal:  Neurology       Date:  2016-12-30       Impact factor: 9.910

Review 5.  Myositis Specific Autoantibodies: A Clinical Perspective.

Authors:  Fahidah M Alenzi
Journal:  Open Access Rheumatol       Date:  2020-01-14

6.  Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash.

Authors:  Yuki Ichimura; Risa Konishi; Miwako Shobo; Sae Inoue; Mari Okune; Akemi Maeda; Ryota Tanaka; Noriko Kubota; Isao Matsumoto; Akiko Ishii; Akira Tamaoka; Asami Shimbo; Masaaki Mori; Tomohiro Morio; Takayuki Kishi; Takako Miyamae; Jantima Tanboon; Michio Inoue; Ichizo Nishino; Manabu Fujimoto; Toshifumi Nomura; Naoko Okiyama
Journal:  Rheumatology (Oxford)       Date:  2022-03-02       Impact factor: 7.580

7.  The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.

Authors:  Mona Shah; Gulnara Mamyrova; Ira N Targoff; Adam M Huber; James D Malley; Madeline Murguia Rice; Frederick W Miller; Lisa G Rider
Journal:  Medicine (Baltimore)       Date:  2013-01       Impact factor: 1.889

Review 8.  Juvenile Dermatomyositis-Clinical Phenotypes.

Authors:  Danyang Li; Sarah L Tansley
Journal:  Curr Rheumatol Rep       Date:  2019-12-11       Impact factor: 4.592
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.